A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes First published 15/07/2024 Last updated 15/07/2024 EU PAS number:EUPAS1000000260 Study Finalised